These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes. Hoermann R; Amir SM; Ingbar SH Endocrinology; 1988 Sep; 123(3):1535-43. PubMed ID: 3402396 [TBL] [Abstract][Full Text] [Related]
4. Inhibition by certain plant extracts of the binding and adenylate cyclase stimulatory effect of bovine thyrotropin in human thyroid membranes. Auf'mkolk M; Ingbar JC; Amir SM; Winterhoff H; Sourgens H; Hesch RD; Ingbar SH Endocrinology; 1984 Aug; 115(2):527-34. PubMed ID: 6745167 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients. Hill BL; Erlanger BF Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350 [TBL] [Abstract][Full Text] [Related]
6. The biological activity of bovine and human thyrotropin is differently affected by trypsin treatment of human thyroid cells: thyroid-stimulating antibody is related to human thyrotropin. Foti D; Russo D; Costante G; Filetti S J Clin Endocrinol Metab; 1991 Oct; 73(4):710-6. PubMed ID: 1679761 [TBL] [Abstract][Full Text] [Related]
7. The distinct roles of alpha- and beta-subunits of human thyrotropin in the receptor-binding and postreceptor events. Endo Y; Tetsumoto T; Nagasaki H; Kashiwai T; Tamaki H; Amino N; Miyai K Endocrinology; 1990 Jul; 127(1):149-54. PubMed ID: 1694490 [TBL] [Abstract][Full Text] [Related]
8. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase. Lefort GP; Amr S; Carayon P; Nisula BC Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue. Clark OH; Gerend PL; Goretzki P; Nissenson RA J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a bioeffective monoclonal antibody against thyrotropin beta-subunit. Hill BL; Lustbader JW; Erlanger BF Endocrinology; 1987 Feb; 120(2):574-81. PubMed ID: 2433128 [TBL] [Abstract][Full Text] [Related]
11. Characterization of monoclonal antibodies to the human thyrotropin receptor. Marion S; Ropars A; Ludgate M; Braun JM; Charreire J Endocrinology; 1992 Feb; 130(2):967-75. PubMed ID: 1733738 [TBL] [Abstract][Full Text] [Related]
12. Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. Thotakura NR; Desai RK; Bates LG; Cole ES; Pratt BM; Weintraub BD Endocrinology; 1991 Jan; 128(1):341-8. PubMed ID: 1846103 [TBL] [Abstract][Full Text] [Related]
13. The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor. Mueller S; Kleinau G; Szkudlinski MW; Jaeschke H; Krause G; Paschke R J Biol Chem; 2009 Jun; 284(24):16317-16324. PubMed ID: 19386596 [TBL] [Abstract][Full Text] [Related]
14. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies. Akamizu T; Mori T; Kasagi K; Kosugi S; Miyamoto M; Nishino K; Sugawa H; Yokota T; Nakamura H; Konishi J Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477 [TBL] [Abstract][Full Text] [Related]
15. Design of a long-lived thyrotropin antagonist from derivatives of human chorionic gonadotropin. Hoermann R; Amir SM; Nomura T; Ingbar SH Endocrinology; 1989 Jan; 124(1):223-32. PubMed ID: 2462487 [TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators. Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871 [TBL] [Abstract][Full Text] [Related]
17. Use of anti-idiotypic antibodies as probes for the interaction of TSH subunits with its receptor. Briones-Urbina R; Islam MN; Ivanyi J; Farid NR J Cell Biochem; 1987 Jul; 34(3):151-62. PubMed ID: 3497159 [TBL] [Abstract][Full Text] [Related]
18. Activities of deglycosylated thyrotropin at the thyroid membrane receptor-adenylate cyclase system. Amr S; Menezez-Ferreira M; Shimohigashi Y; Chen HC; Nisula B; Weintraub BD J Endocrinol Invest; 1985 Dec; 8(6):537-41. PubMed ID: 3009595 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antiidiotypic antibodies interact with the 93 kilodalton thyrotropin receptor and exhibit heterogeneous biological activities. Costagliola S; Ruf J; Durand-Gorde MJ; Carayon P Endocrinology; 1991 Mar; 128(3):1555-62. PubMed ID: 1999172 [TBL] [Abstract][Full Text] [Related]
20. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]